Celldex Therapeutics said on Thursday it would stop developing its experimental drug for eczema after the treatment failed to meet the main and key secondary goals of a mid-stage study.
Celldex ends eczema drug development after mid-stage trial failure
Celldex Therapeutics said on Thursday it would stop developing its experimental drug for eczema after the treatment failed to meet the main and key secondary goals of a mid-stage study.
Want trade ideas like this in real time? Subscribe to Trade Conquest.
